BioVie Inc. (BIVI)
BioVie Inc. - BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinsons Disease ahead of Topline Data in 2Q26, on May 7, 2026
BioVie Inc. - BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinsons Disease ahead of Topline Data in 2Q26, on May 7, 2026
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak signals • Minimal impact expected **Sentiment:** Neutral (50%) **Content type:** General